drugset / Trial / NCT00439374

RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix

NCT00439374

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of early delivery and improves the health of their baby.

Timeline

Start
2007-04
Primary completion
2011-05
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator 17-alpha-hydroxyprogesterone caproate Unknown 250 mg Intramuscular

Indications

No indication recorded.